Navigation Links
Cell response to stress signals predicts tumors in women with common pre-breast cancer
Date:11/12/2007

A specific biological response to cellular stress may predict the likelihood of future tumor formation of the most common, non-invasive form of pre-malignant breast cancer-- ductal carcinoma in situ, or DCIS.

This information could potentially be used in a clinical setting to determine which women should receive more or less aggressive therapy when initially diagnosed with DCIS, according to a study led by researchers from the University of California, San Francisco.

The research results are also significant because traditional tests available today are not strong enough to predict whether or not a woman will develop a future cancer after diagnosis with DCIS. By identifying this particular biological response in patients, physicians may now be able to predict subsequent tumor formation years before it actually occurs.

The study is the cover story of the November 13, 2007 issue of Cancer Cell. It is a translational study that brings together an integrated team of basic and clinical scientists in an attempt to find molecular markers to aid women and their physicians in determining the best treatment option following a diagnosis of DCIS.

We were very excited by the results, said senior author Thea Tlsty, PhD, professor of pathology and co-leader of the Cell Cycling and Signaling Program of the UCSF Comprehensive Cancer Center. Until now, little has been known about the molecular pathways that may cause a differential risk in women diagnosed with this type of breast pre- malignancy.

DCIS is a type of breast cancer where cancer cells form inside the milk ducts of the breast but have not spread to surrounding breast tissue. DCIS accounts for nearly 25 percent of all breast cancer diagnoses, according to the American Cancer Society.

In the absence of this new information, the researchers said, women diagnosed with DCIS today are often offered a gamut of treatment options that extend from a full mastectomy
'/>"/>

Contact: Vanessa deGier
vdegier@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Key to out-of-control immune response in lung injury found
2. Flies can turn off their immune response
3. Auto immune response creates barrier to fertility; could be a step in speciation
4. Doctors learn to control their own brains pain responses to better treat patients
5. UVA researchers explain cell response to skin-damaging UV rays
6. Agent that triggers immune response in plants is uncovered
7. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
8. Influenza vaccine causes weaker immune response for children of rural Gabon than in semi-urban areas
9. Triage study challenges notions of emergency medical response to disaster
10. Mice stressed in simulated weightlessness show organ atrophy
11. Heat stress influences low conception of dairy herds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)...lif. -- More than 160 participants gathered this w... FUTURES INITIATIVE conference. This year,s topic,... engineers, and medical researchers to explore the...nding the emerging field of synthetic biology. , ... at Princeton University and this year,s conferenc...
(Date:11/23/2009)... Calif. - By producing some of the highest resolut...es, scientists have a deeper understanding how bio...earch may lead to a new treatment for kidney stone...ars in the Nov. 23 online edition of the journal ...explores how peptides interact with mineral surfac...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 1New Initiative to Improve Mental Health Among Chicago Latinos 52989 2New Initiative to Improve Mental Health Among Chicago Latinos 52989 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 4Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 1Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 1Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 3
...ed the term "slobber knocker," is there a limit to... handle before the player suffers a concussion" , ...the University of North Carolina at Chapel Hill. H...Carolina football players over the 2004 to 2006 se...l theories about these mild traumatic brain injuri...
...ot of botanical diversity, there are more than 20,...ral thousand of them are used by traditional heale...of problems from the common cold to serious diseas...tments are will be the focus of The International ...), a collaborative research effort between the Uni...
...he United States Department of Agriculture (USDA) ...techniques" used in the production of packaged pro...ue of HortScience, simulated washing techniques to...ality and safety of pre-cut lettuce. , Yaguang Lu...tates Department of Agriculture,s (USDA) Produce Q...
Other Biology News:High-tech helmets reveal new information about the impact of hard hits to the head 2High-tech helmets reveal new information about the impact of hard hits to the head 3High-tech helmets reveal new information about the impact of hard hits to the head 4Study of African traditional medicine will begin world-first clinical trial 2Study of African traditional medicine will begin world-first clinical trial 3Fresh-cut produce washing practices can minimize food-borne illness risks 2
(Date:11/24/2009)...stCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )wi...cember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interest...rnetavailableat http://inve s tor.sig m a a ...ssthisfile. ,, AboutSigma-Aldrich: Sigma-Ald...Itschemicalandbiochemicalproductsandkitsareusedins...
(Date:11/24/2009)...a/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&a...ationalnewdrugapplication(IND)foritsoralinsulinpro...tdiabetes.ThisIND,approvalallowsBiolaxytoinitiatei...rdercharacteristicofhighbloodglucoseandpoor,metabo...micro-and,macro-vasculardiseases,lossofvision,kidn...
(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...
(Date:11/24/2009)...tracts Service (CAS), the global expert on chemica...is now the world,s leading producer of patent inve...an,s patent office, the World Intellectual Propert...t and Trademark Office (USPTO) for more than a dec...nd exceeded Japan for the first time on a monthly ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... - Completed Series B Total Stands at EUR21.3 m ... focused on novel therapeutic,and preventative app...oday,announced that Roche Venture Fund and Enterpr...llion to the Series B financing announced in Febru... million. The new investors,join Novartis Venture ...
...lable in French . , An NSERC-funded lab at the U...a lithium battery that can store and deliver more ... ion batteries. , The research team of professor... postdoctoral fellow Kyu Tae Lee are one of the fi...nce for a lithium-sulphur battery. The finding is ...
...8 Charleston Laboratories, Inc., an emerging spec... opioid-induced nausea and vomiting (OINV) in opio...lly completed the Exploratory Bioequivalence Study... "These are promising data on our immediate-relea...ief Operating Officer at Charleston Laboratories, ...
Other Biology Technology:Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Canadian research team reports major breakthrough in lithium battery technology 2Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 2
... StabilCoat Plus Microsphere/Microarray Stabilizer...ovine protein and other non-toxic chemicals in a P.... This product contains a combination of 0.02% me... preservative. StabilCoat Plus Stabilizer provide...
... The Corning CellBIND surface is produced by a pat...ilic surface giving more consistent, even cell att...D enhances cell attachment and growth uunder diffi...free medium. • CellBIND may provide a more ec...
Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
... Powerful data acquisition, analysis and experimen...rker data with on-line and off-line analysis. powe...in script language allowing the user to customize ...ns range from basic data logging to complex setups...
Biology Products: